Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Features

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

Michael O'Riordan

October 17, 2025

News Conference News HRS 2025

BIO-LIBRA: Outcomes Vary by Sex, Device in Cardiomyopathy Patients With ICDs

Todd Neale

May 02, 2025

News Conference News THT 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

Todd Neale

February 21, 2025

News Daily News

Acute HF Patients Live Longer When Seen by Specialists

Michael O'Riordan

August 09, 2024

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

News Conference News ESC Heart Failure 2024

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

Michael O'Riordan

May 21, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

News Daily News

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

Michael O'Riordan

February 19, 2024

News Daily News

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Michael O'Riordan

September 18, 2023

News Conference News TVT 2023

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

Michael O'Riordan

June 12, 2023

News Conference News THT 2023

Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF

Todd Neale

March 21, 2023

News Features

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

Shelley Wood

December 20, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

News Daily News

Prognosis of Myocarditis Following COVID-19 Vaccination ‘Favorable’

Michael O'Riordan

March 28, 2022

News Daily News

Familial Patterns of Idiopathic Dilated Cardiomyopathy Becoming Clearer

L.A. McKeown

February 10, 2022

Advertisement

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Cardiac Transplant in Midst of ‘Revolution,’ but Public Trust Is Fragile

BIO-LIBRA: Outcomes Vary by Sex, Device in Cardiomyopathy Patients With ICDs

Positive Results With Carillon Mitral Device Seen in Real-world Registries

Acute HF Patients Live Longer When Seen by Specialists

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Prognosis of Myocarditis Following COVID-19 Vaccination ‘Favorable’

Familial Patterns of Idiopathic Dilated Cardiomyopathy Becoming Clearer

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content